IVF Services Market is segmented By Cycle Type (Fresh IVF Cycles, Thawed IVF Cycles, Donor Egg IVF Cycles), By End-User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview
IVF Services Market is expected to grow at a CAGR 16.3% during the forecast period (2024-2031).
IVF (In-vitro fertilization) is an Assisted Reproductive Technology (ART) where an egg and sperm are fertilized outside the body to develop an embryo. It is also used when a woman has problems associated with ovulation, fibroids, polycystic ovarian syndrome, endometriosis, and cervical issues or when the reasons for infertility are unclear.
Market Summary
|
Metrics |
Details |
|
Market CAGR |
16.3% |
|
Segments Covered |
By Cycle Type, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
For More Insights about the Market Request Free Sample
Market Trends
- The global market for the IVF Services market is primarily driven by rising infertility rates, increasing delayed pregnancies, a surge in IVF success rates, and rising disposable income globally. According to the American Society for Reproductive Medicine (ASRM), infertility affects around 6.7 million women in the U.S, which accounts for around 11.0% of the reproductive population in 2018. Ina addition, 25% of the couples have more than one factor leading to infertility.
- However, high cost of IVF services, low awareness, and complications associated with IVF treatment are some of the factors restraining the growth of the IVF services market.
Market Segmentation Analysis
- Based on cycle type, the global market for IVF Services is segmented into fresh IVF cycles (non-donor), Thawed IVF cycles (non-donor), and donor egg IVF cycles. Among these, Fresh IVF cycles (non-donor) segment accounted for the largest market share in 2018 due to its high success rate in the first attempt. Thawed IVF cycles (non-donor) segment is growing at the fastest rate during the forecast period as procedure can be performed in complicated cases such as on a patient suffering from Ovarian Hyperstimulation Syndrome (OHSS). In addition, the procedure reduced the case of ectopic pregnancy, gives a better implantation rate, higher live birth rate, which are driving the demand for the procedure globally.
- Based on end-users, the market is classified into hospitals, fertility clinics, surgical centers, and clinical research institute. Among these, fertility clinics segment accounted for the largest market share in 2018 due to rising demand for ART treatments, the number of fertility clinics and assisted reproductive technology (ART) centers is increasing considerably.
Market Geographical Share
- The North America region occupied the largest market share of the global IVF services market in 2018 and is estimated to dominate over the forecast period.
- The Asia-Pacific region is expected to have highest growth rate during the forecast period with China, Japan, and India being the main contributors. The Asia-Pacific IVF services is growing due to low cost of treatment as compared to developed regions, and availability of advanced technology. The Asia Pacific Initiative on Reproduction (ASPIRE), a task force of clinicians and scientists involved in the monitoring and management of fertility and ART. Thus, such organizations are promoting awareness regarding ART and infertility in the Asia-Pacific region.
Companies and Competitive Landscape
- Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with an increased focus on R&D are other ways the leading players improve their market presence. For instance, In July 2018, Merck, a leading science and technology company, launched QBOX IVF, and the new Geri® Assess 2.0, to become the preferred treatment partner for all IVF stakeholders and assisted reproductive treatment (ART) clinics.
- Few of the major contributors for IVF services market are Heidelberg University Hospital, Cyprus IVF Centre, Life sure Fertility & Gynaecology Centre, Gynaecoloqisch Centrum, BFC Biofertility Center, Servy Massey Fertility Institute, IVF NAMBA Clinic, Southend Fertility, and IVF Centre, EMD Serono, Inc. and Clnica EUGIN Barcelona, among others.
